Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02373592
Other study ID # 1R21TW009982
Secondary ID
Status Completed
Phase N/A
First received February 20, 2015
Last updated December 13, 2017
Start date September 2015
Est. completion date October 2017

Study information

Verified date August 2017
Source Universidad Peruana Cayetano Heredia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to implement daily temperature measurements of feet complemented by SMS and voice messaging to prevent diabetic foot ulcers in patients with type 2 diabetes mellitus at high risk of ulceration.

Design: Physician-blinded, randomized, 18-month trial.

Setting: Diabetes outpatient clinics from two public hospitals

Population: Subjects will be eligible if they (1) have a diagnosis of type 2 diabetes mellitus, (2) are between 18 - 80 years of age, (3) have a present dorsalis pedis pulse in both feet, (4) are in risk group 2 or 3 using the diabetic foot risk classification system as specified by the International Working Group on the Diabetic Foot, (5) have an operating cell phone or a caregiver with an operating cell phone, and (6) have the ability to provide informed consent.

Hypothesis: The investigators hypothesize that implementation of an enhanced intervention that combines daily temperature measurement for the reduction of diabetic foot ulcer with SMS and voice messaging will improve patient measurement compliance and reduce diabetic foot ulcers in a middle income country.


Description:

Detailed Description:

Thermometry is a promising emerging modality for the prevention of diabetic foot ulcers according to different clinical trials. However, patient compliance with self-monitoring temperature at home is a concern, as they may be forgetful or find it difficult to get into a consistent routine of daily monitoring. Therefore, the investigators propose to determine the utility of SMS and voice messaging to remind the patients to perform the thermometry, and to assess the impact on diabetic foot ulceration.

Specific Aims are:

1. Compare the incidence of diabetic foot ulceration during the study between the arm that receives thermometry alone and the arm that receives thermometry plus SMS and voice messaging.

2. Compare the compliance with foot thermometer use between the two study arms.

3. Compare the frequency of alarms signs reported to the study nurse in the two study arms.

4. Compare the frequency of alarms signs reported in the patient's logbooks in the two study arms.

5. Compare the incidence of diabetic foot ulceration according to pre-specified sub-groups: caregiving status, and use of insoles and/or orthopedic shoes.

6. In the intervention-only group, compare the incidence of diabetic foot ulcers by varying the recipient of the messaging intervention (patient vs caregivers).

Intervention:

1. Placebo Comparator: Thermometry-only group. Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet through colors.

Some alarm signs have been pre-specified: 1) When the thermal image shows yellow spots in any area of any feet for two consecutive days, 2) when the thermal image shows different colors in contralateral areas of the feet for two consecutive days or, 3) a dermal lesion is detected at any time. In any of these three scenarios, subjects will be instructed to contact the study nurse by phone or text message.

For the first two types of alarm signs, once the study nurse is contacted he/ she will ask about the presence of lesions in the patient's feet and the patient's activity on the previous two weeks, and will provide recommendations on how to decrease activity until temperatures normalize. If TempStat measurements continue to show alarm signs for more than one week after the telephone consultation, the participant will be asked to contact the nurse and schedule a face-to-face evaluation to assess the presence of an infection and/or ulcer with a masked assessor.

In the third type of alarm sign, presence of a dermal lesion, participants will be asked to contact the study's nurse and he/she will make an appointment for an evaluation with a nurse blind to the intervention.

When the main outcome, foot ulceration, has been confirmed, patients will be directed by the study nurse to receive professional care by a specialist.

2. Experimental: Thermometry plus SMS and voice messaging Thermometry-related intervention activities will be the same as those established for the thermometry-only group. In addition, this group will receive reminders to use the TempStat (two messages) and promote foot care (six messages). The content of these eight messages has been developed and validated through both via SMS and voice messaging. During the first two weeks of the intervention, only reminders to use the TempStat will be sent, daily, Monday to Friday, both SMS and voice messaging. Hereafter, for the remaining 76 weeks, patients will only receive two messages per week, one SMS and one voice message, alternating content (reminders to use TempStat and promotion of foot care).


Recruitment information / eligibility

Status Completed
Enrollment 172
Est. completion date October 2017
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Diagnosis of type 2 diabetes mellitus.

- Dorsalis pedis pulse in both feet.

- In risk group 2 or 3 using the diabetic foot risk classification system as specified by the International Working Group on the Diabetic Foot.

- Operating cell phone or a caregiver with an operating cell phone.

- Ability to provide informed consent.

Exclusion Criteria:

- Current ulcers or open amputation sites.

- Active osteoarthropathy

- Severe peripheral vascular disease

- Foot infection

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
SMS and voice messaging
This group will receive reminders to use the TempStat (two messages) and promote foot care (six messages). The content of these eight messages have been developed and validated their delivery through both, SMS and voice messaging. During the first two weeks of the intervention, only reminders to use the TempStat will be sent, daily, Monday to Friday, both via SMS and voice messaging. Hereafter, for the remaining 76 weeks, patients will only receive two messages per week, one SMS and one voice message, alternating content (reminders to use TempStat and promotion of foot care).
Device:
Thermometry
Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet. (See Detailed description)

Locations

Country Name City State
Peru Hospital Cayetano Heredia Lima
Peru Hospital Nacional Arzobispo Loayza Lima

Sponsors (4)

Lead Sponsor Collaborator
Universidad Peruana Cayetano Heredia Johns Hopkins University, Mayo Clinic, University of Southern California

Country where clinical trial is conducted

Peru, 

References & Publications (1)

Lazo-Porras M, Bernabe-Ortiz A, Sacksteder KA, Gilman RH, Malaga G, Armstrong DG, Miranda JJ. Implementation of foot thermometry plus mHealth to prevent diabetic foot ulcers: study protocol for a randomized controlled trial. Trials. 2016 Apr 19;17(1):206. doi: 10.1186/s13063-016-1333-1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Sub-group analyses, all participants The primary outcome will be subjected to pre-specified heterogeneity in treatment effects. In the following analyses, variables will be considered positive if its presence/usage is reported at baseline and in at the last evaluation of the participant during study period.
Caregiving status, assistance provided to the patient with i) basic activities of daily living, or ii) in the identification, prevention, or treatment of diabetes or any disability.
Use of insoles and/or orthopedic shoes.
18 months
Other Sub-group analyses, intervention group only 1)In order to receive the SMS and voice messaging, the intervention requires ownership of a cell phone by either the patient or its caregiver. This sub-group analysis will explore the primary outcome by the type of recipient (patient vs caregivers) of the messaging intervention. 18 months
Primary Foot ulceration The primary outcome is foot ulceration occurring at any point during the 12 month study duration.
Foot ulceration will be defined using the American Diabetes Association criteria, which defines ulcers as any break in the cutaneous barrier; that usually extend through the full thickness of the dermis. There will be two ways of identifying if a patient has developed foot ulceration: (1) during the clinical evaluations done by a nurse every 2 months. (2) In addition to these bimonthly assessments, patients will be advised to make telephone calls to the study's nurse to report the presence of an ulcer, and he/she will be asked to go to the hospital for a face-to-face evaluation to be conducted by a masked nurse.
18 months
Secondary Adherence to daily temperature measurement Adherence to temperature measurements will be based on patient self-report of foot temperature monitoring through recording in patient's logbooks. 18 months
Secondary Report of an alarm sign to the nurse Compare the frequency of alarms signs reported to the study nurse 18 months
Secondary Report of an alarm sign in the logbook Compare the frequency of alarms signs reported in the patient's logbooks. 18 months
Secondary Dose-response analysis of SMS and voice messaging Dose-response per protocol analysis will be performed. 18 months
Secondary Glycosilated hemoglobin control targets Reduce of 1% or more of glycosylated hemoglobin. 18 months
See also
  Status Clinical Trial Phase
Recruiting NCT06154915 - Immune Cells in Diabetic Chronic Foot Ulcers
Completed NCT04624516 - Effect of Self-foot Exercise on the Incidence of Plantar Foot Diabetic Ulcer Recurrence N/A
Active, not recruiting NCT01903044 - Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating Phase 1/Phase 2
Completed NCT02092870 - Adipose Derived Regenerative Cellular Therapy of Chronic Wounds Phase 2
Completed NCT01212120 - The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections N/A
Completed NCT00402727 - Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection Phase 3
Recruiting NCT04085705 - The Prevalence of Contact Allergies for Wound Dressings In Patients With Diabetic Foot Ulcers (PAID Study)
Completed NCT04054804 - Digital Foot Check by Using the D-Foot, a New Software
Not yet recruiting NCT04537676 - Patient Empowerment Study
Completed NCT04480801 - The Effect of Thermal Evaluation in Prevention of Diabetic Foot Ulcer N/A
Recruiting NCT04564443 - A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot N/A
Recruiting NCT05974592 - The Effect of Nurse-Led Diabetic Foot Self-Management Training Program N/A
Not yet recruiting NCT04630795 - ViscoTurf - Preventing Secondary Diabetic Foot Ulceration.
Not yet recruiting NCT05431660 - Diabetic Foot School and Biomechanics N/A
Completed NCT05101473 - Exercise Therapy for People With a Diabetic Foot Ulcer - a Feasibility Study N/A
Completed NCT05123157 - Pattern and Type of Amputation and Mortality Rate Associated With Diabetic Foot in Jeddah, Saudi Arabia: A Retrospective Cohort Study
Enrolling by invitation NCT05043636 - Diabetic Neuropathy Screening Study 1.1 + Substudy 1.2-1.3-1.4
Completed NCT03254095 - Predictors of Skin Temperature, Plantar Pressure and Ulceration in Diabetic Foot Patients.
Terminated NCT01657318 - Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
Completed NCT06373809 - Placenta Derived Stem Cells for Treating of Chronic Ulcers and Neuropathy Early Phase 1